Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56651 - 56675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	SDC4	6385	upregulated	panobinostat results in increased expression of SDC4 mRNA	20q13.12	A21037
Panobinostat	Approved Investigational	SEC24D	9871	upregulated	panobinostat results in increased expression of SEC24D mRNA	4q26	A21037
Panobinostat	Approved Investigational	SELENOI	85465	upregulated	panobinostat results in increased expression of SELENOI mRNA	2p23.3	A21037
Panobinostat	Approved Investigational	SELENOP	6414	upregulated	panobinostat results in increased expression of SELENOP mRNA	5p12	A21037
Panobinostat	Approved Investigational	SEMA3C	10512	upregulated	panobinostat results in increased expression of SEMA3C mRNA	7q21.11	A21037
Panobinostat	Approved Investigational	SEMA3E	9723	upregulated	panobinostat results in increased expression of SEMA3E mRNA	7q21.11	A21037
Panobinostat	Approved Investigational	SEMA5A	9037	downregulated	panobinostat results in decreased expression of SEMA5A mRNA	5p15.31	A21037
Panobinostat	Approved Investigational	SEMA6D	80031	downregulated	panobinostat results in decreased expression of SEMA6D mRNA	15q21.1	A21037
Panobinostat	Approved Investigational	SEPT6	23157	upregulated	panobinostat results in increased expression of SEPT6 mRNA	Xq24	A21037
Panobinostat	Approved Investigational	SERPINB9	5272	upregulated	panobinostat results in increased expression of SERPINB9 mRNA	6p25.2	A21037
Panobinostat	Approved Investigational	SERPINF1	5176	downregulated	panobinostat results in decreased expression of SERPINF1 mRNA	17p13.3	A21037
Panobinostat	Approved Investigational	SESTD1	91404	downregulated	panobinostat results in decreased expression of SESTD1 mRNA	2q31.2	A21037
Panobinostat	Approved Investigational	SEZ6	124925	upregulated	panobinostat results in increased expression of SEZ6 mRNA	17q11.2	A21037
Panobinostat	Approved Investigational	SFMBT1	51460	downregulated	panobinostat results in decreased expression of SFMBT1 mRNA	3p21.1	A21037
Panobinostat	Approved Investigational	SFMBT2	57713	upregulated	panobinostat results in increased expression of SFMBT2 mRNA	10p14	A21037
Panobinostat	Approved Investigational	SFN	2810	upregulated	panobinostat results in increased expression of SFN mRNA	1p36.11	A21037
Panobinostat	Approved Investigational	SFRP1	6422	downregulated	panobinostat results in decreased expression of SFRP1 mRNA	8p11.21	A21037
Panobinostat	Approved Investigational	SFRP2	6423	downregulated	panobinostat results in decreased expression of SFRP2 mRNA	4q31.3	A21037
Panobinostat	Approved Investigational	SGK3	23678	upregulated	panobinostat results in increased expression of SGK3 mRNA	8q13.1	A21037
Panobinostat	Approved Investigational	SGPP1	81537	upregulated	panobinostat results in increased expression of SGPP1 mRNA	14q23.2	A21037
Panobinostat	Approved Investigational	SGPP2	130367	upregulated	panobinostat results in increased expression of SGPP2 mRNA	2q36.1	A21037
Panobinostat	Approved Investigational	SH3KBP1	30011	upregulated	panobinostat results in increased expression of SH3KBP1 mRNA	Xp22.12	A21037
Panobinostat	Approved Investigational	SHB	6461	upregulated	panobinostat results in increased expression of SHB mRNA	9p13.1	A21037
Panobinostat	Approved Investigational	SIX1	6495	upregulated	panobinostat results in increased expression of SIX1 mRNA	14q23.1	A21037
Panobinostat	Approved Investigational	SIX3	6496	downregulated	panobinostat results in decreased expression of SIX3 mRNA	2p21	A21037

Displaying entries 56651 - 56675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability